Key result
Cardiomyocyte SUR2 deletion cuts infarct area by ~19 percentage points after ischemia-reperfusion.
Why the study?
SUR2 was previously implicated in the myocardial transition from glycolytic to oxidative metabolism during postnatal adaptation, prompting investigation of its selective deletion in adult myocardium.
Does conditional deletion of sulfonylurea receptor 2 (SUR2) in the adult mouse myocardium enhance cardiac glucose uptake and protect against ischemia-reperfusion and isoproterenol-induced myocardial injury?
Does conditional deletion of sulfonylurea receptor 2 (SUR2) in the adult mouse myocardium enhance cardiac glucose uptake and protect against ischemia-reperfusion and isoproterenol-induced myocardial injury?
Answers are grounded in this paper and cite their sources.
Selective ablation of SUR2 in adult mouse cardiomyocytes interacts with GLUT4 to boost insulin-dependent glucose uptake and glycolysis, conferring cardioprotection against ischemia-reperfusion and isoproterenol injury despite a mild baseline reduction in systolic function.
The adult myocardium relies on oxidative metabolism. In ischemic myocardium, such as the embryonic heart, glycolysis contributes more prominently as a fuel source. The sulfonylurea receptor 2 (SUR2) was previously implicated in the normal myocardial transition from glycolytic to oxidative metabolism that occurs during adaptation to postnatal life. This receptor was now selectively deleted in adult mouse myocardium resulting in protection from ischemia reperfusion injury. SUR2-deleted cardiomyocytes had enhanced glucose uptake, and SUR2 forms a complex with the major glucose transporter. These data identify the SUR2 receptor as a target to shift cardiac metabolism to protect against myocardial injury.
No takes yet. Share an insight, caveat, or question.
Aubert et al. (2019) studied Myocardial ischemia-reperfusion injury and cardiac metabolism. Cardiomyocyte-specific Abcc9 (SUR2) deletion induced by tamoxifen vs. Tamoxifen-treated MCM Cre- Fl Ex5 control mice was evaluated on Infarct area (%) after 30 minutes of global ex vivo ischemia and 60 minutes of reperfusion (p=0.03). Cardiomyocyte-specific SUR2 deletion in adult mice reduced infarct area after 30-minute ischemia-reperfusion from 33±6.3% to 13.6±1.2% and enhanced cardiac glucose uptake.
Synapse has enriched 10 related papers. Consider them for comparative context: